Please note, this OEL/ADE monograph also applies to citalopram hydrochloride (CAS RN 85118-27-0) and citalopram hydrobromide (CAS RN 59729-32-7). Citalopram belongs to a class of antidepressant agents known as selective serotoninreuptake inhibitors (SSRIs) and is widely used to treat the symptoms of depression. Citalopram is indicated for the treatment of major depressive disorder (MDD) in adults. It is also used for the treatment of depressive illness in the initial phase and as maintenance against potential relapse/recurrence. Additionally, citalopram is indicated in the treatment of panic disorder with or without agoraphobia. It has been found to relieve or manage symptoms of depression, anxiety, eating disorders, and obsessive-compulsive disorder, among other mood disorders.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Citalopram, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.